0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genome Editing Enzymes Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-6C20013
Home | Market Reports | Science| Biological Sciences
Global Genome Editing Enzymes Market Research Report 2025
BUY CHAPTERS

Global Genome Editing Enzymes Market Research Report 2025

Code: QYRE-Auto-6C20013
Report
September 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Genome Editing Enzymes Market Size

The global market for Genome Editing Enzymes was valued at US$ 432 million in the year 2024 and is projected to reach a revised size of US$ 613 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Genome Editing Enzymes Market

Genome Editing Enzymes Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Genome Editing Enzymes competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Genome editing enzymes are specialized proteins that can recognize, cut, or modify specific DNA sequences within an organism’s genome, enabling precise genetic alterations. The most well-known are nucleases such as CRISPR-Cas systems, TALENs (Transcription Activator-Like Effector Nucleases), and ZFNs (Zinc Finger Nucleases), which create targeted double-strand breaks that cells repair, allowing insertion, deletion, or correction of genes. Other enzymes, like base editors and prime editors, can make more subtle nucleotide-level changes without cutting both DNA strands. These tools are widely applied in biomedical research, agriculture, and potential therapies, offering unprecedented control over gene function for purposes ranging from disease modeling to crop improvement. Published list prices show wide dispersion: research-grade Cas proteins from ~€81 for 70 pmol Cas12a to ~€289 for 2000 pmol, ~$879–$1,022 for 500 µg Cas9.
North American market for Genome Editing Enzymes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Genome Editing Enzymes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Genome Editing Enzymes include Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies (IDT), Takara Bio, New England Biolabs, GenScript, Aldevron, TriLink Biotechnologies, Synthego, KACTUS Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Genome Editing Enzymes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genome Editing Enzymes.
The Genome Editing Enzymes market size, estimations, and forecasts are provided in terms of sales volume (µg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genome Editing Enzymes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genome Editing Enzymes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Genome Editing Enzymes Market Report

Report Metric Details
Report Name Genome Editing Enzymes Market
Accounted market size in year US$ 432 million
Forecasted market size in 2031 US$ 613 million
CAGR 5.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • CRISPR-Associated (Cas) Enzymes
  • Base Editing Enzymes
  • Prime Editors
  • Others
Segment by Application
  • Basic Research
  • Biomedicine
  • Agriculture
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies (IDT), Takara Bio, New England Biolabs, GenScript, Aldevron, TriLink Biotechnologies, Synthego, KACTUS Bio, Fortis Life Sciences, Shandong Shunfeng Biotechnology, Renman Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Genome Editing Enzymes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Genome Editing Enzymes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Genome Editing Enzymes Market growing?

Ans: The Genome Editing Enzymes Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Genome Editing Enzymes Market size in 2031?

Ans: The Genome Editing Enzymes Market size in 2031 will be US$ 613 million.

Who are the main players in the Genome Editing Enzymes Market report?

Ans: The main players in the Genome Editing Enzymes Market are Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies (IDT), Takara Bio, New England Biolabs, GenScript, Aldevron, TriLink Biotechnologies, Synthego, KACTUS Bio, Fortis Life Sciences, Shandong Shunfeng Biotechnology, Renman Biotechnology

What are the Application segmentation covered in the Genome Editing Enzymes Market report?

Ans: The Applications covered in the Genome Editing Enzymes Market report are Basic Research, Biomedicine, Agriculture, Others

What are the Type segmentation covered in the Genome Editing Enzymes Market report?

Ans: The Types covered in the Genome Editing Enzymes Market report are CRISPR-Associated (Cas) Enzymes, Base Editing Enzymes, Prime Editors, Others

1 Genome Editing Enzymes Market Overview
1.1 Product Definition
1.2 Genome Editing Enzymes by Type
1.2.1 Global Genome Editing Enzymes Market Value Comparison by Type (2024 VS 2031)
1.2.2 CRISPR-Associated (Cas) Enzymes
1.2.3 Base Editing Enzymes
1.2.4 Prime Editors
1.2.5 Others
1.3 Genome Editing Enzymes by Application
1.3.1 Global Genome Editing Enzymes Market Value by Application (2024 VS 2031)
1.3.2 Basic Research
1.3.3 Biomedicine
1.3.4 Agriculture
1.3.5 Others
1.4 Global Genome Editing Enzymes Market Size Estimates and Forecasts
1.4.1 Global Genome Editing Enzymes Revenue 2020-2031
1.4.2 Global Genome Editing Enzymes Sales 2020-2031
1.4.3 Global Genome Editing Enzymes Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Genome Editing Enzymes Market Competition by Manufacturers
2.1 Global Genome Editing Enzymes Sales Market Share by Manufacturers (2020-2025)
2.2 Global Genome Editing Enzymes Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Genome Editing Enzymes Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Genome Editing Enzymes, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genome Editing Enzymes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genome Editing Enzymes, Product Type & Application
2.7 Global Key Manufacturers of Genome Editing Enzymes, Date of Enter into This Industry
2.8 Global Genome Editing Enzymes Market Competitive Situation and Trends
2.8.1 Global Genome Editing Enzymes Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Genome Editing Enzymes Players Market Share by Revenue
2.8.3 Global Genome Editing Enzymes Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Genome Editing Enzymes Market Scenario by Region
3.1 Global Genome Editing Enzymes Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Genome Editing Enzymes Sales by Region: 2020-2031
3.2.1 Global Genome Editing Enzymes Sales by Region: 2020-2025
3.2.2 Global Genome Editing Enzymes Sales by Region: 2026-2031
3.3 Global Genome Editing Enzymes Revenue by Region: 2020-2031
3.3.1 Global Genome Editing Enzymes Revenue by Region: 2020-2025
3.3.2 Global Genome Editing Enzymes Revenue by Region: 2026-2031
3.4 North America Genome Editing Enzymes Market Facts & Figures by Country
3.4.1 North America Genome Editing Enzymes Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Genome Editing Enzymes Sales by Country (2020-2031)
3.4.3 North America Genome Editing Enzymes Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Genome Editing Enzymes Market Facts & Figures by Country
3.5.1 Europe Genome Editing Enzymes Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Genome Editing Enzymes Sales by Country (2020-2031)
3.5.3 Europe Genome Editing Enzymes Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genome Editing Enzymes Market Facts & Figures by Region
3.6.1 Asia Pacific Genome Editing Enzymes Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Genome Editing Enzymes Sales by Region (2020-2031)
3.6.3 Asia Pacific Genome Editing Enzymes Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Genome Editing Enzymes Market Facts & Figures by Country
3.7.1 Latin America Genome Editing Enzymes Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Genome Editing Enzymes Sales by Country (2020-2031)
3.7.3 Latin America Genome Editing Enzymes Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Genome Editing Enzymes Market Facts & Figures by Country
3.8.1 Middle East and Africa Genome Editing Enzymes Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Genome Editing Enzymes Sales by Country (2020-2031)
3.8.3 Middle East and Africa Genome Editing Enzymes Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genome Editing Enzymes Sales by Type (2020-2031)
4.1.1 Global Genome Editing Enzymes Sales by Type (2020-2025)
4.1.2 Global Genome Editing Enzymes Sales by Type (2026-2031)
4.1.3 Global Genome Editing Enzymes Sales Market Share by Type (2020-2031)
4.2 Global Genome Editing Enzymes Revenue by Type (2020-2031)
4.2.1 Global Genome Editing Enzymes Revenue by Type (2020-2025)
4.2.2 Global Genome Editing Enzymes Revenue by Type (2026-2031)
4.2.3 Global Genome Editing Enzymes Revenue Market Share by Type (2020-2031)
4.3 Global Genome Editing Enzymes Price by Type (2020-2031)
5 Segment by Application
5.1 Global Genome Editing Enzymes Sales by Application (2020-2031)
5.1.1 Global Genome Editing Enzymes Sales by Application (2020-2025)
5.1.2 Global Genome Editing Enzymes Sales by Application (2026-2031)
5.1.3 Global Genome Editing Enzymes Sales Market Share by Application (2020-2031)
5.2 Global Genome Editing Enzymes Revenue by Application (2020-2031)
5.2.1 Global Genome Editing Enzymes Revenue by Application (2020-2025)
5.2.2 Global Genome Editing Enzymes Revenue by Application (2026-2031)
5.2.3 Global Genome Editing Enzymes Revenue Market Share by Application (2020-2031)
5.3 Global Genome Editing Enzymes Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific Genome Editing Enzymes Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Company Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck KGaA Genome Editing Enzymes Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Integrated DNA Technologies (IDT)
6.3.1 Integrated DNA Technologies (IDT) Company Information
6.3.2 Integrated DNA Technologies (IDT) Description and Business Overview
6.3.3 Integrated DNA Technologies (IDT) Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Integrated DNA Technologies (IDT) Genome Editing Enzymes Product Portfolio
6.3.5 Integrated DNA Technologies (IDT) Recent Developments/Updates
6.4 Takara Bio
6.4.1 Takara Bio Company Information
6.4.2 Takara Bio Description and Business Overview
6.4.3 Takara Bio Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takara Bio Genome Editing Enzymes Product Portfolio
6.4.5 Takara Bio Recent Developments/Updates
6.5 New England Biolabs
6.5.1 New England Biolabs Company Information
6.5.2 New England Biolabs Description and Business Overview
6.5.3 New England Biolabs Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.5.4 New England Biolabs Genome Editing Enzymes Product Portfolio
6.5.5 New England Biolabs Recent Developments/Updates
6.6 GenScript
6.6.1 GenScript Company Information
6.6.2 GenScript Description and Business Overview
6.6.3 GenScript Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GenScript Genome Editing Enzymes Product Portfolio
6.6.5 GenScript Recent Developments/Updates
6.7 Aldevron
6.7.1 Aldevron Company Information
6.7.2 Aldevron Description and Business Overview
6.7.3 Aldevron Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Aldevron Genome Editing Enzymes Product Portfolio
6.7.5 Aldevron Recent Developments/Updates
6.8 TriLink Biotechnologies
6.8.1 TriLink Biotechnologies Company Information
6.8.2 TriLink Biotechnologies Description and Business Overview
6.8.3 TriLink Biotechnologies Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.8.4 TriLink Biotechnologies Genome Editing Enzymes Product Portfolio
6.8.5 TriLink Biotechnologies Recent Developments/Updates
6.9 Synthego
6.9.1 Synthego Company Information
6.9.2 Synthego Description and Business Overview
6.9.3 Synthego Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Synthego Genome Editing Enzymes Product Portfolio
6.9.5 Synthego Recent Developments/Updates
6.10 KACTUS Bio
6.10.1 KACTUS Bio Company Information
6.10.2 KACTUS Bio Description and Business Overview
6.10.3 KACTUS Bio Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.10.4 KACTUS Bio Genome Editing Enzymes Product Portfolio
6.10.5 KACTUS Bio Recent Developments/Updates
6.11 Fortis Life Sciences
6.11.1 Fortis Life Sciences Company Information
6.11.2 Fortis Life Sciences Description and Business Overview
6.11.3 Fortis Life Sciences Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Fortis Life Sciences Genome Editing Enzymes Product Portfolio
6.11.5 Fortis Life Sciences Recent Developments/Updates
6.12 Shandong Shunfeng Biotechnology
6.12.1 Shandong Shunfeng Biotechnology Company Information
6.12.2 Shandong Shunfeng Biotechnology Description and Business Overview
6.12.3 Shandong Shunfeng Biotechnology Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shandong Shunfeng Biotechnology Genome Editing Enzymes Product Portfolio
6.12.5 Shandong Shunfeng Biotechnology Recent Developments/Updates
6.13 Renman Biotechnology
6.13.1 Renman Biotechnology Company Information
6.13.2 Renman Biotechnology Description and Business Overview
6.13.3 Renman Biotechnology Genome Editing Enzymes Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Renman Biotechnology Genome Editing Enzymes Product Portfolio
6.13.5 Renman Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genome Editing Enzymes Industry Chain Analysis
7.2 Genome Editing Enzymes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genome Editing Enzymes Production Mode & Process Analysis
7.4 Genome Editing Enzymes Sales and Marketing
7.4.1 Genome Editing Enzymes Sales Channels
7.4.2 Genome Editing Enzymes Distributors
7.5 Genome Editing Enzymes Customer Analysis
8 Genome Editing Enzymes Market Dynamics
8.1 Genome Editing Enzymes Industry Trends
8.2 Genome Editing Enzymes Market Drivers
8.3 Genome Editing Enzymes Market Challenges
8.4 Genome Editing Enzymes Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Genome Editing Enzymes Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Genome Editing Enzymes Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Genome Editing Enzymes Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Genome Editing Enzymes Sales (µg) of Key Manufacturers (2020-2025)
 Table 5. Global Genome Editing Enzymes Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Genome Editing Enzymes Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Genome Editing Enzymes Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Genome Editing Enzymes Average Price (US$/µg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Genome Editing Enzymes, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Genome Editing Enzymes, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Genome Editing Enzymes, Product Type & Application
 Table 12. Global Key Manufacturers of Genome Editing Enzymes, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Genome Editing Enzymes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome Editing Enzymes as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Genome Editing Enzymes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Genome Editing Enzymes Sales by Region (2020-2025) & (µg)
 Table 18. Global Genome Editing Enzymes Sales Market Share by Region (2020-2025)
 Table 19. Global Genome Editing Enzymes Sales by Region (2026-2031) & (µg)
 Table 20. Global Genome Editing Enzymes Sales Market Share by Region (2026-2031)
 Table 21. Global Genome Editing Enzymes Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Genome Editing Enzymes Revenue Market Share by Region (2020-2025)
 Table 23. Global Genome Editing Enzymes Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Genome Editing Enzymes Revenue Market Share by Region (2026-2031)
 Table 25. North America Genome Editing Enzymes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Genome Editing Enzymes Sales by Country (2020-2025) & (µg)
 Table 27. North America Genome Editing Enzymes Sales by Country (2026-2031) & (µg)
 Table 28. North America Genome Editing Enzymes Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Genome Editing Enzymes Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Genome Editing Enzymes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Genome Editing Enzymes Sales by Country (2020-2025) & (µg)
 Table 32. Europe Genome Editing Enzymes Sales by Country (2026-2031) & (µg)
 Table 33. Europe Genome Editing Enzymes Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Genome Editing Enzymes Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Genome Editing Enzymes Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Genome Editing Enzymes Sales by Region (2020-2025) & (µg)
 Table 37. Asia Pacific Genome Editing Enzymes Sales by Region (2026-2031) & (µg)
 Table 38. Asia Pacific Genome Editing Enzymes Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Genome Editing Enzymes Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Genome Editing Enzymes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Genome Editing Enzymes Sales by Country (2020-2025) & (µg)
 Table 42. Latin America Genome Editing Enzymes Sales by Country (2026-2031) & (µg)
 Table 43. Latin America Genome Editing Enzymes Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Genome Editing Enzymes Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Genome Editing Enzymes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Genome Editing Enzymes Sales by Country (2020-2025) & (µg)
 Table 47. Middle East and Africa Genome Editing Enzymes Sales by Country (2026-2031) & (µg)
 Table 48. Middle East and Africa Genome Editing Enzymes Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Genome Editing Enzymes Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Genome Editing Enzymes Sales (µg) by Type (2020-2025)
 Table 51. Global Genome Editing Enzymes Sales (µg) by Type (2026-2031)
 Table 52. Global Genome Editing Enzymes Sales Market Share by Type (2020-2025)
 Table 53. Global Genome Editing Enzymes Sales Market Share by Type (2026-2031)
 Table 54. Global Genome Editing Enzymes Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Genome Editing Enzymes Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Genome Editing Enzymes Revenue Market Share by Type (2020-2025)
 Table 57. Global Genome Editing Enzymes Revenue Market Share by Type (2026-2031)
 Table 58. Global Genome Editing Enzymes Price (US$/µg) by Type (2020-2025)
 Table 59. Global Genome Editing Enzymes Price (US$/µg) by Type (2026-2031)
 Table 60. Global Genome Editing Enzymes Sales (µg) by Application (2020-2025)
 Table 61. Global Genome Editing Enzymes Sales (µg) by Application (2026-2031)
 Table 62. Global Genome Editing Enzymes Sales Market Share by Application (2020-2025)
 Table 63. Global Genome Editing Enzymes Sales Market Share by Application (2026-2031)
 Table 64. Global Genome Editing Enzymes Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Genome Editing Enzymes Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Genome Editing Enzymes Revenue Market Share by Application (2020-2025)
 Table 67. Global Genome Editing Enzymes Revenue Market Share by Application (2026-2031)
 Table 68. Global Genome Editing Enzymes Price (US$/µg) by Application (2020-2025)
 Table 69. Global Genome Editing Enzymes Price (US$/µg) by Application (2026-2031)
 Table 70. Thermo Fisher Scientific Company Information
 Table 71. Thermo Fisher Scientific Description and Business Overview
 Table 72. Thermo Fisher Scientific Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 73. Thermo Fisher Scientific Genome Editing Enzymes Product
 Table 74. Thermo Fisher Scientific Recent Developments/Updates
 Table 75. Merck KGaA Company Information
 Table 76. Merck KGaA Description and Business Overview
 Table 77. Merck KGaA Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 78. Merck KGaA Genome Editing Enzymes Product
 Table 79. Merck KGaA Recent Developments/Updates
 Table 80. Integrated DNA Technologies (IDT) Company Information
 Table 81. Integrated DNA Technologies (IDT) Description and Business Overview
 Table 82. Integrated DNA Technologies (IDT) Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 83. Integrated DNA Technologies (IDT) Genome Editing Enzymes Product
 Table 84. Integrated DNA Technologies (IDT) Recent Developments/Updates
 Table 85. Takara Bio Company Information
 Table 86. Takara Bio Description and Business Overview
 Table 87. Takara Bio Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 88. Takara Bio Genome Editing Enzymes Product
 Table 89. Takara Bio Recent Developments/Updates
 Table 90. New England Biolabs Company Information
 Table 91. New England Biolabs Description and Business Overview
 Table 92. New England Biolabs Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 93. New England Biolabs Genome Editing Enzymes Product
 Table 94. New England Biolabs Recent Developments/Updates
 Table 95. GenScript Company Information
 Table 96. GenScript Description and Business Overview
 Table 97. GenScript Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 98. GenScript Genome Editing Enzymes Product
 Table 99. GenScript Recent Developments/Updates
 Table 100. Aldevron Company Information
 Table 101. Aldevron Description and Business Overview
 Table 102. Aldevron Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 103. Aldevron Genome Editing Enzymes Product
 Table 104. Aldevron Recent Developments/Updates
 Table 105. TriLink Biotechnologies Company Information
 Table 106. TriLink Biotechnologies Description and Business Overview
 Table 107. TriLink Biotechnologies Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 108. TriLink Biotechnologies Genome Editing Enzymes Product
 Table 109. TriLink Biotechnologies Recent Developments/Updates
 Table 110. Synthego Company Information
 Table 111. Synthego Description and Business Overview
 Table 112. Synthego Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 113. Synthego Genome Editing Enzymes Product
 Table 114. Synthego Recent Developments/Updates
 Table 115. KACTUS Bio Company Information
 Table 116. KACTUS Bio Description and Business Overview
 Table 117. KACTUS Bio Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 118. KACTUS Bio Genome Editing Enzymes Product
 Table 119. KACTUS Bio Recent Developments/Updates
 Table 120. Fortis Life Sciences Company Information
 Table 121. Fortis Life Sciences Description and Business Overview
 Table 122. Fortis Life Sciences Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 123. Fortis Life Sciences Genome Editing Enzymes Product
 Table 124. Fortis Life Sciences Recent Developments/Updates
 Table 125. Shandong Shunfeng Biotechnology Company Information
 Table 126. Shandong Shunfeng Biotechnology Description and Business Overview
 Table 127. Shandong Shunfeng Biotechnology Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 128. Shandong Shunfeng Biotechnology Genome Editing Enzymes Product
 Table 129. Shandong Shunfeng Biotechnology Recent Developments/Updates
 Table 130. Renman Biotechnology Company Information
 Table 131. Renman Biotechnology Description and Business Overview
 Table 132. Renman Biotechnology Genome Editing Enzymes Sales (µg), Revenue (US$ Million), Price (US$/µg) and Gross Margin (2020-2025)
 Table 133. Renman Biotechnology Genome Editing Enzymes Product
 Table 134. Renman Biotechnology Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Genome Editing Enzymes Distributors List
 Table 138. Genome Editing Enzymes Customers List
 Table 139. Genome Editing Enzymes Market Trends
 Table 140. Genome Editing Enzymes Market Drivers
 Table 141. Genome Editing Enzymes Market Challenges
 Table 142. Genome Editing Enzymes Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Genome Editing Enzymes
 Figure 2. Global Genome Editing Enzymes Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Genome Editing Enzymes Market Share by Type: 2024 & 2031
 Figure 4. CRISPR-Associated (Cas) Enzymes Product Picture
 Figure 5. Base Editing Enzymes Product Picture
 Figure 6. Prime Editors Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Genome Editing Enzymes Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Genome Editing Enzymes Market Share by Application: 2024 & 2031
 Figure 10. Basic Research
 Figure 11. Biomedicine
 Figure 12. Agriculture
 Figure 13. Others
 Figure 14. Global Genome Editing Enzymes Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Genome Editing Enzymes Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Genome Editing Enzymes Sales (2020-2031) & (µg)
 Figure 17. Global Genome Editing Enzymes Average Price (US$/µg) & (2020-2031)
 Figure 18. Genome Editing Enzymes Report Years Considered
 Figure 19. Genome Editing Enzymes Sales Share by Manufacturers in 2024
 Figure 20. Global Genome Editing Enzymes Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Genome Editing Enzymes Players: Market Share by Revenue in Genome Editing Enzymes in 2024
 Figure 22. Genome Editing Enzymes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Genome Editing Enzymes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Genome Editing Enzymes Sales Market Share by Country (2020-2031)
 Figure 25. North America Genome Editing Enzymes Revenue Market Share by Country (2020-2031)
 Figure 26. United States Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Genome Editing Enzymes Sales Market Share by Country (2020-2031)
 Figure 29. Europe Genome Editing Enzymes Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Genome Editing Enzymes Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Genome Editing Enzymes Revenue Market Share by Region (2020-2031)
 Figure 37. China Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Genome Editing Enzymes Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Genome Editing Enzymes Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Genome Editing Enzymes Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Genome Editing Enzymes Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Genome Editing Enzymes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Genome Editing Enzymes by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Genome Editing Enzymes by Type (2020-2031)
 Figure 57. Global Genome Editing Enzymes Price (US$/µg) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Genome Editing Enzymes by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Genome Editing Enzymes by Application (2020-2031)
 Figure 60. Global Genome Editing Enzymes Price (US$/µg) by Application (2020-2031)
 Figure 61. Genome Editing Enzymes Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart